Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,504 | -9,394 | -39,740 | -30,997 | -21,793 |
| Depreciation Amortization | 2,318 | 557 | 214 | 152 | 111 |
| Income taxes - deferred | 33 | 264 | 1,057 | 793 | 529 |
| Accounts receivable | -1,079 | -4,049 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -4,240 | -2,672 | 8,767 | 5,167 | 4,441 |
| Other Working Capital | 12,599 | -8,893 | 1,053 | 7,433 | 6,661 |
| Other Operating Activity | 13,564 | 11,178 | 2,096 | 2,780 | 786 |
| Operating Cash Flow | $-14,309 | $-13,009 | $-26,553 | $-14,672 | $-9,265 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -5,000 | -4,400 | -5,750 | 0 | 0 |
| Investing Cash Flow | $-5,000 | $-4,400 | $-5,750 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,300 | 1,300 | N/A |
| Common Stock Issued | 20,816 | 20,878 | 32,303 | 16,509 | 6,040 |
| Other Financing Activity | -1,169 | 0 | -300 | -300 | 0 |
| Financing Cash Flow | $19,647 | $20,878 | $33,303 | $17,509 | $6,040 |
| Beginning Cash Position | 4,252 | 4,252 | 3,252 | 3,252 | 3,252 |
| End Cash Position | 4,590 | 7,721 | 4,252 | 6,089 | 26 |
| Net Cash Flow | $338 | $3,469 | $1,000 | $2,837 | $-3,226 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,309 | -13,009 | -26,553 | -14,672 | -9,265 |
| Free Cash Flow | -14,309 | -13,009 | -26,553 | -14,672 | -9,265 |